{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2008"],"condition":["lung cancer, pharyngeal cancer, gastric cancer, jejunal cancer, ileal cancer,  pancreas cancer, biliary tract cancer,  soft tissue sarcoma"],"disease":["Lung Cancer, Pharyngeal Cancer, Gastric Cancer, Jejunal Cancer, Ileal Cancer,  Pancreas Cancer, Biliary Tract Cancer,  Soft Tissue Sarcoma"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2618328"],"location":["Japan"],"study_start_month":["12"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Phase II study of peptide vaccination for patients with metastatic lung or gastro-intestinal tract cancers","description":"Interventions: peptide vaccinnation\nPrimary outcome(s): Evaluation of efficacy by RECIST criteria\nStudy Design: Single arm Non-randomized","dates":{"creation":"2008-12-15"},"accession":"2618328","cross_references":{"Japan Primary Registries Network":["JPRN-UMIN000002857"]}}